Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
|Podcasts|April 28, 2022
Dr. Michael Lutz on the urologist as an advocate for men's health
Author(s)Urology Times staff
“As urologists, we see men of all ages, and one of the things that we need to do is…take advantage of being their advocates for health care,” says Michael Lutz, MD.
Advertisement
In this episode, Urology Times® Assistant Managing Editor Ben Saylor spoke with Dr. Michael Lutz about how urologists can be advocates for men’s health. Lutz is a partner in the Michigan Institute of Urology and president of the MIU Men’s Health Foundation.
Advertisement
Related to this article
Heather Florio joins to discuss the potential role of supplements in pelvic and sexual health.
Pearls & Perspectives: Expanding Sexual Health Conversations Through Digital Media, With Wendy Brant
Amy Pearlman, MD, and Wendy Brant discuss building a digital audience, navigating sexual health content online, and the role of communication in relationships.
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
2
FDA updates in urology: September 2026
3
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
4
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
5